Literature DB >> 26718721

Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.

Anne Lejay1, Fei Fang2, Rohan John3, Julie A D Van2, Meredith Barr2, Fabien Thaveau4, Nabil Chakfe4, Bernard Geny5, James W Scholey2.   

Abstract

Ischemia/reperfusion, which is characterized by deficient oxygen supply and subsequent restoration of blood flow, can cause irreversible damages to tissue. Mechanisms contributing to the pathogenesis of ischemia reperfusion injury are complex, multifactorial and highly integrated. Extensive research has focused on increasing organ tolerance to ischemia reperfusion injury, especially through the use of ischemic conditioning strategies. Of morbidities that potentially compromise the protective mechanisms of the heart, diabetes mellitus appears primarily important to study. Diabetes mellitus increases myocardial susceptibility to ischemia reperfusion injury and also modifies myocardial responses to ischemic conditioning strategies by disruption of intracellular signaling responsible for enhancement of resistance to cell death. The purpose of this review is twofold: first, to summarize mechanisms underlying ischemia reperfusion injury and the signal transduction pathways underlying ischemic conditioning cardioprotection; and second, to focus on diabetes mellitus and mechanisms that may be responsible for the lack of effect of ischemic conditioning strategies in diabetes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718721     DOI: 10.1016/j.yjmcc.2015.12.020

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  79 in total

1.  Association between ROS production, swelling and the respirasome integrity in cardiac mitochondria.

Authors:  Sehwan Jang; Sabzali Javadov
Journal:  Arch Biochem Biophys       Date:  2017-07-20       Impact factor: 4.013

2.  Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart.

Authors:  Graham R McGinnis; Yawen Tang; Rachel A Brewer; Manoja K Brahma; Haley L Stanley; Gobinath Shanmugam; Namakkal Soorappan Rajasekaran; Glenn C Rowe; Stuart J Frank; Adam R Wende; E Dale Abel; Heinrich Taegtmeyer; Silvio Litovsky; Victor Darley-Usmar; Jianhua Zhang; John C Chatham; Martin E Young
Journal:  J Mol Cell Cardiol       Date:  2017-07-20       Impact factor: 5.000

3.  Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation.

Authors:  Wenjun Li; Guoshuai Feng; Jason M Gauthier; Inessa Lokshina; Ryuji Higashikubo; Sarah Evans; Xinping Liu; Adil Hassan; Satona Tanaka; Markus Cicka; Hsi-Min Hsiao; Daniel Ruiz-Perez; Andrea Bredemeyer; Richard W Gross; Douglas L Mann; Yulia Y Tyurina; Andrew E Gelman; Valerian E Kagan; Andreas Linkermann; Kory J Lavine; Daniel Kreisel
Journal:  J Clin Invest       Date:  2019-02-26       Impact factor: 14.808

4.  Chronic AICAR treatment prevents metabolic changes in cardiomyocytes exposed to free fatty acids.

Authors:  Christelle Viglino; Bernard Foglia; Christophe Montessuit
Journal:  Pflugers Arch       Date:  2019-05-31       Impact factor: 3.657

Review 5.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

6.  Cytochrome c is an oxidative stress-activated plasmalogenase that cleaves plasmenylcholine and plasmenylethanolamine at the sn-1 vinyl ether linkage.

Authors:  Christopher M Jenkins; Kui Yang; Gaoyuan Liu; Sung Ho Moon; Beverly G Dilthey; Richard W Gross
Journal:  J Biol Chem       Date:  2018-03-12       Impact factor: 5.157

Review 7.  Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

Authors:  Abdullah Kaplan; Emna Abidi; Ahmed El-Yazbi; Ali Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

8.  Naringenin alleviates myocardial ischemia reperfusion injury by enhancing the myocardial miR-126-PI3K/AKT axis in streptozotocin-induced diabetic rats.

Authors:  Shang-Hai Li; Ming-Shuang Wang; Wei-Liang Ke; Ming-Rui Wang
Journal:  Exp Ther Med       Date:  2021-05-27       Impact factor: 2.447

Review 9.  Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis.

Authors:  Xiao-Dong Ye; Yi He; Sheng Wang; Gordon T Wong; Michael G Irwin; Zhengyuan Xia
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

10.  Remote Limb Ischemic Conditioning and Motor Learning: Evaluation of Factors Influencing Response in Older Adults.

Authors:  Ellen N Sutter; Anna E Mattlage; Marghuretta D Bland; Kendra M Cherry-Allen; Elinor Harrison; Swati M Surkar; Jeffrey M Gidday; Ling Chen; Tamara Hershey; Jin-Moo Lee; Catherine E Lang
Journal:  Transl Stroke Res       Date:  2018-08-07       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.